High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors.

about

High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors.

Item

http://www.wikidata.org/entity/Q41124092

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

High-level production of repli ...... -dependent adenovirus vectors.

@en

type

Item

label

High-level production of repli ...... -dependent adenovirus vectors.

@en

prefLabel

High-level production of repli ...... -dependent adenovirus vectors.

@en

P1476

High-level production of repli ...... -dependent adenovirus vectors.

@en

P2093

Donna Palmer

http://www.w3.org/2001/XMLSchema#string

Kaitlin O'Boyle

http://www.w3.org/2001/XMLSchema#string

Philip Ng

http://www.w3.org/2001/XMLSchema#string

Richard E Sutton

http://www.w3.org/2001/XMLSchema#string

Yani Hu

http://www.w3.org/2001/XMLSchema#string

P2860

TAP binds to the constitutive transport element (CTE) through a novel RNA-binding motif that is sufficient to promote CTE-dependent RNA export from the nucleus

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus

Efficacy of gene therapy for X-linked severe combined immunodeficiency

The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences

Transcription start regions in the human genome are favored targets for MLV integration

P304

15004

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MTM.2015.4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276932942

http://www.w3.org/2001/XMLSchema#string

P698

26029715

http://www.w3.org/2001/XMLSchema#string

P921

Adenoviridae

vector-borne disease

P932

4444993

http://www.w3.org/2001/XMLSchema#string